Clozapine and anemia: A 2-year follow-up study

Journal of Clinical Psychiatry

Volumn 76, Issue 12, 2015, Pages 1642-1647

  Lee, Jimmy ^a,b,c   Bies, Robert ^c,d,e   Bhaloo, Amaal ^c   Powell, Valerie ^c   Remington, Gary ^c,f  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Indiana Clinical and Translational Sciences Institute   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HEMOGLOBIN; NEUROLEPTIC AGENT;

ADULT; AGRANULOCYTOSIS; ANEMIA; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; DELUSIONAL DISORDER; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY ANEMIA; MACROCYTIC ANEMIA; MAJOR CLINICAL STUDY; MALE; NORMOCHROMIC NORMOCYTIC ANEMIA; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SEX DIFFERENCE; SMOKING; BLOOD; CHEMICALLY INDUCED; INCIDENCE; MENTAL DISORDERS; METABOLISM; REGRESSION ANALYSIS; TIME FACTOR;

ADULT; ANEMIA; ANTIPSYCHOTIC AGENTS; CLOZAPINE; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; INCIDENCE; MALE; MENTAL DISORDERS; REGRESSION ANALYSIS; SEX FACTORS; SMOKING; TIME FACTORS;

EID: 84954212996     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.14m09143     Document Type: Article

References (31)

1. Remington GJ, Addington D, Collins EJ, et al. Clozapine: current status and role in the pharmacotherapy of schizophrenia. Can J Psychiatry. 1996;41(3):161-166.
2. Salzman C. Mandatory monitoring for side effects: the "bundling" of clozapine. N Engl J Med. 1990;323(12):827-829.
3. Baldessarini RJ, Frankenburg FR. Clozapine: a novel antipsychotic agent. N Engl J Med. 1991;324(11):746-754.
4. Lahdelma L, Appelberg B. Clozapine-induced agranulocytosis in Finland, 1982-2007: longterm monitoring of patients is still warranted. J Clin Psychiatry. 2012;73(6):837-842.
5. Munro J, O'Sullivan D, Andrews C, et al. Active monitoring of 12,760 clozapine recipients in the UK and Ireland: beyond pharmacovigilance. Br J Psychiatry. 1999;175(6):576-580.
6. Hummer M, Kurz M, Barnas C, et al. Clozapineinduced transient white blood count disorders. J Clin Psychiatry. 1994;55(10):429-432.
7. Hummer M, Sperner-Unterweger B, Kemmler G, et al. Does eosinophilia predict clozapine induced neutropenia? Psychopharmacology (Berl). 1996;124(1-2):201-204.
8. Marlowe K. Thrombocytosis due to clozapine treatment: working towards an early marker for clozapine-induced agranulocytosis. Br J Psychiatry. 2000;177(4):372-373.
9. Lambertenghi Deliliers G. Blood dyscrasias in clozapine-treated patients in Italy. Haematologica. 2000;85(3):233-237.
10. Nooijen PM, Carvalho F, Flanagan RJ. Haematological toxicity of clozapine and some other drugs used in psychiatry. Hum Psychopharmacol. 2011;26(2):112-119.
11. Gerson SL, Arce C, Meltzer HY. N-desmethylclozapine: a clozapine metabolite that suppresses haemopoiesis. Br J Haematol. 1994;86(3):555-561.
12. Lucca U, Tettamanti M, Mosconi P, et al. Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: the "Health and Anemia" study. PLoS ONE. 2008;3(4):e1920.
13. Schoepf D, Uppal H, Potluri R, et al. Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions. Eur Arch Psychiatry Clin Neurosci. 2014;264(1):3-28.
14. Jankowska EA, Ponikowski P. Molecular changes in myocardium in the course of anemia or iron deficiency. Heart Fail Clin. 2010;6(3):295-304.
15. Laursen TM, Munk-Olsen T, Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry. 2012;25(2):83-88.
16. Layland JJ, Liew D, Prior DL. Clozapine-induced cardiotoxicity: a clinical update. Med J Aust. 2009;190(4):190-192.
17. Ziegenbein M, Steinbrecher A, Garlipp P. Clozapine-induced aplastic anemia in a patient with Parkinson's disease. Can J Psychiatry. 2003;48(5):352.
18. Benoist B, McLean E, Egli I, et al, eds. Worldwide prevalence of anaemia 1993-2005: WHO Global Database on Anaemia. Geneva, Switzerland: WHO Press; 2008.
19. Seppälä NH, Leinonen EV, Lehtonen ML, et al. Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients. Pharmacol Toxicol. 1999;85(5):244-246.
20. Nordenberg D, Yip R, Binkin NJ. The effect of cigarette smoking on hemoglobin levels and anemia screening. JAMA. 1990;264(12):1556-1559.
21. Grossman C, Dovrish Z, Koren-Morag N, et al. Diabetes mellitus with normal renal function is associated with anaemia. Diabetes Metab Res Rev. 2014;30(4):291-296.
22. Leshem-Rubinow E, Steinvil A, Zeltser D, et al. Association of angiotensin-converting enzyme inhibitor therapy initiation with a reduction in hemoglobin levels in patients without renal failure. Mayo Clin Proc. 2012;87(12):1189-1195.
23. Smeeth L, Douglas I, Hall AJ, et al. Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials. Br J Clin Pharmacol. 2009;67(1):99-109.
24. Griffith RW, Saameli K. Clozapine and agranulocytosis. Lancet. 1975;2(7936):657.
25. Uetrecht JP. Metabolism of clozapine by neutrophils. Possible implications for clozapine-induced agranulocytosis. Drug Saf. 1992;7(suppl 1):51-56.
26. Lahdelma L, Oja S, Korhonen M, et al. Clozapine is cytotoxic to primary cultures of human bone marrow mesenchymal stromal cells. J Clin Psychopharmacol. 2010;30(4):461-463.
27. Sperner-Unterweger B, Gaggl S, Fleischhacker WW, et al. Effects of clozapine on hematopoiesis and the cytokine system. Biol Psychiatry. 1993;34(8):536-543.
28. Pisciotta AV, Konings SA, Ciesemier LL, et al. Cytotoxic activity in serum of patients with clozapine-induced agranulocytosis. J Lab Clin Med. 1992;119(3):254-266.
29. Meltzer HY, Alphs L, Green AI, et al; International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry. 2003;60(1):82-91.
30. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011-1023.
31. Bergink V, Gibney SM, Drexhage HA. Autoimmunity, inflammation, and psychosis: a search for peripheral markers. Biol Psychiatry. 2014;75(4):324-331.